Literature DB >> 9952106

Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.

J M Ward1, L Tadesse-Heath, S N Perkins, S K Chattopadhyay, S D Hursting, H C Morse.   

Abstract

The molecular pathology and histogenesis of lymphomas in 56 retired breeder male and 14 12-week-old male homozygous p53-deficient (p53-/-) mice (C57BL/6TacfBR-[KO]p53 N4) were evaluated. Lymphomas were assessed by serial morphologic techniques, immunohistochemistry, flow cytometry, and analysis of T cell receptor (TCR) or immunoglobulin heavy chain (IgH) gene rearrangements. We found two common types of lymphomas. T-cell lymphomas arose in the thymus through a sequence of lymphocyte depletion, medullary hyperplasia, and unilateral lymphoma. Tumor cells were CD3+, CD90+, and usually TCRalpha/beta+ and possessed clonal TCRbeta gene rearrangements. Thymic lymphoblastic lymphomas (LL) were highly malignant and quickly metastasized to the splenic white pulp and liver, even when the thymus was only slightly increased in weight. In the spleen, a novel lymphoma was found. Marginal zone hyperplasia led to marginal zone lymphoma (MZL), a well-differentiated lymphoma that usually expressed CD45R (B220) and CD5 at low levels and that had clonal IgH gene rearrangements. IgH gene rearrangements were also seen in spleens with marginal zone hyperplasias only. Hyperplastic and neoplastic marginal zone B cells expressed IgM at low to normal levels, as seen by FACS analysis and immunohistochemistry. These tumors only metastasized to the liver at a later stage, as they became less differentiated. Several mice had both types of tumors present in the spleen. Two B-cell lymphoblastic lymphomas of uncertain origin were also found. In this article, we discuss the possible mechanisms responsible for development of the lymphomas seen in these p53-deficient mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952106

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

1.  Splenic marginal zone lymphomas of mice.

Authors:  T N Fredrickson; K Lennert; S K Chattopadhyay; H C Morse; J W Hartley
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Authors:  Hyunjoo Lee; Shabirul Haque; Jennifer Nieto; Joshua Trott; John K Inman; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

3.  Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control.

Authors:  Jene Choi; Bonnie Nannenga; Oleg N Demidov; Dmitry V Bulavin; Austin Cooney; Cory Brayton; Yongxin Zhang; Innocent N Mbawuike; Allan Bradley; Ettore Appella; Lawrence A Donehower
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  RBL1 (p107) functions as tumor suppressor in glioblastoma and small-cell pancreatic neuroendocrine carcinoma in Xenopus tropicalis.

Authors:  Thomas Naert; Dionysia Dimitrakopoulou; Dieter Tulkens; Suzan Demuynck; Marjolein Carron; Rivka Noelanders; Liza Eeckhout; Gert Van Isterdael; Dieter Deforce; Christian Vanhove; Jo Van Dorpe; David Creytens; Kris Vleminckx
Journal:  Oncogene       Date:  2020-01-30       Impact factor: 9.867

Review 5.  Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias.

Authors:  Jerrold M Ward; Jerold E Rehg; Herbert C Morse
Journal:  Toxicol Pathol       Date:  2012-01-03       Impact factor: 1.902

6.  Loss of DNA polymerase zeta enhances spontaneous tumorigenesis.

Authors:  John P Wittschieben; Vaishali Patil; Veronika Glushets; Lisa J Robinson; Donna F Kusewitt; Richard D Wood
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

7.  Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.

Authors:  Monica Gostissa; Julia M Bianco; Daniel J Malkin; Jeffery L Kutok; Scott J Rodig; Herbert C Morse; Craig H Bassing; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  Utility of antiPax5 in the diagnosis of lymphoproliferative disorders and neoplasia in mice.

Authors:  Jerold E Rehg; John P Sundberg
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

9.  Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23.

Authors:  David MacPherson; Jungho Kim; Teresa Kim; Byung Kirl Rhee; Conny Th M Van Oostrom; Richard A DiTullio; Monica Venere; Thanos D Halazonetis; Roderick Bronson; Annemieke De Vries; Mark Fleming; Tyler Jacks
Journal:  EMBO J       Date:  2004-09-02       Impact factor: 11.598

10.  Finding mouse models of human lymphomas and leukemia's using the Jackson laboratory mouse tumor biology database.

Authors:  Dale A Begley; John P Sundberg; Debra M Krupke; Steven B Neuhauser; Carol J Bult; Janan T Eppig; Herbert C Morse; Jerrold M Ward
Journal:  Exp Mol Pathol       Date:  2015-08-21       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.